Data from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia

MLA

Junmin Li, et al. Data from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.c.6532559.

APA

Junmin Li, Xiaoyang Li, Yunxiang Zhang, Ran Li, Shishuang Wu, Wei Zhang, Jie Shen, Zeyi Li, Ge Jiang, Fangyi Dong, Ming Zhao, Xiaoling Wang, Qiqi Jin, & Peng Jin. (2023). Data from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia. https://doi.org/10.1158/1078-0432.c.6532559

Chicago

Junmin Li, Xiaoyang Li, Yunxiang Zhang, Ran Li, Shishuang Wu, Wei Zhang, Jie Shen, et al. 2023. “Data from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia,” March. doi:10.1158/1078-0432.c.6532559.